Results 91 to 100 of about 1,405,949 (200)

Monetised estimated quality-adjusted life year (QALY) losses for non-fatal injuries. [PDF]

Inj Prev, 2022
Miller GF, Florence C, Barnett SB, Peterson C, Lawrence BA, Miller TR.   +5 more
europepmc   +1 more source

Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China. [PDF]

Appl Health Econ Health Policy, 2022
Ye Z, Abduhilil R, Huang J, Sun L.
europepmc   +1 more source

Protocol for estimating the willingness-to-pay-based value for a quality-adjusted life year to aid health technology assessment in India: a cross-sectional study. [PDF]

BMJ Open, 2023
Chugh Y, Jyani G, Trivedi M, Albert S, Kar SS, Patro B, Raman S, Rajsekar K, Baker RM, Donaldson C, Prinja S.   +10 more
europepmc   +1 more source

Fundamental Measurement and Quality-Adjusted Life Years [PDF]

Value in Health, 2021
Paul C, Langley, Stephen P, McKenna
openaire   +2 more sources

Price Indices for Information and Communication Technology Industries - An Application to the German PC Market [PDF]

, 2001
Changing product quality, rapid technological progress, and short product life cycles make it difficult to compute indices that correctly reflect the true price movements of IT products. This paper assesses the differences between traditional and quality
Moch, Dietmar
core  

Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life. [PDF]

Eur J Health Econ, 2022
Cai D, Shi S, Jiang S, Si L, Wu J, Jiang Y.   +5 more
europepmc   +1 more source

Comparison of partitioned survival modeling with state transition modeling approaches with or without consideration of brain metastasis: a case study of Osimertinib versus pemetrexed-platinum

BMC Cancer
Background The partitioned survival model (PSM) and the state transition model (STM) are widely used in cost-effectiveness analyses of anticancer drugs.
Yoon-Bo Shim, Byeong-Chan Oh, Eui-Kyung Lee, Mi-Hai Park   +3 more
doaj   +1 more source

Comparing the monetary value of a quality-adjusted life year from the payment card and the open-ended format. [PDF]

Cost Eff Resour Alloc, 2021
Ye Z, Liu F, Ma J, Zhou Z, Wang C, Sun L.   +5 more
europepmc   +1 more source

Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States. [PDF]

Value Health, 2021
Basu A, Gandhay VJ.
europepmc   +1 more source

A reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: Results based on the Women's Health Initiative randomised controlled trial [PDF]

, 2004
The cost-effectiveness of hormone replacement therapy (HRT) based on a societal perspective is reassessed based on new medical evidence found in the Women's Health Initiative (WHI).
Borgström, Fredrik, Jönsson, Bengt, Kanis, John, Zethraeus, Niklas   +3 more
core